title: Effect of short-term treatment with recombinant human growth hormone on lipids and lipoproteins in women and men without growth hormone disturbances.
abstract: The effect of recombinant human growth hormone (rHGH) on cholesterol, high- and low-density lipoprotein (HDL and LDL) cholesterol, triglycerides (TG), apolipoprotein (apo) B, apo A-I, and lipoprotein(a) [Lp(a)] was studied in 40 postmenopausal women treated with 0.05, 0.1, or 0.2 IU/kg/d rHGH or placebo for 7 days. Cholesterol, LDL cholesterol, and HDL cholesterol decreased in a dose-dependent manner (P = .001, P = .001, and P = .003, respectively), whereas apo B decreased insignificantly (P = .15). Apo A-I decreased significantly only among women treated with rHGH at a dose of 0.1 IU/kg/d (P = .03). When all rHGH-treated women were grouped together, Lp(a) increased (P = .001). We also studied 20 young men treated with either 0.2 IU/kg/d rHGH or placebo. As in women, cholesterol and apo B decreased P = .005 and P = .02, respectively), whereas Lp(a) increased (P = .05). There was no detectable effect of rHGH on TG concentrations in men. As in women, there was no significant effect of 0.2 IU/kg/d rHGH on apo A-I concentrations. All lipid and lipoprotein measures reached pretreatment levels during the first week after treatment was stopped, except Lp(a), which remained elevated 2 weeks after rHGH cessation.
authors.affiliation: Department of Internal Medicine and Cardiology A, Aarhus University Hospital, Denmark.
authors.forename: P S
authors.initials: PS
authors.lastname: Hansen
authors.forename: M
authors.initials: M
authors.lastname: Kassem
authors.forename: K
authors.initials: K
authors.lastname: Brixen
authors.forename: I C
authors.initials: IC
authors.lastname: Klausen
authors.forename: L
authors.initials: L
authors.lastname: Mosekilde
authors.forename: O
authors.initials: O
authors.lastname: Faergeman
mesh_terms: D000368:Aged; D002784:Cholesterol / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D013006:Growth Hormone / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D008055:Lipids / Q000097:blood*; D017270:Lipoprotein(a) / Q000097:blood; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012016:Reference Values; D012727:Sex Characteristics; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
chemical_list: D008055:Lipids; D017270:Lipoprotein(a); D008074:Lipoproteins; D011994:Recombinant Proteins; D014280:Triglycerides; D013006:Growth Hormone; D002784:Cholesterol